推荐COPD药物未获处的相关因素:一项人群研究
该研究在加拿大安大略省利用健康行政数据,纳入2018年≥66岁医生诊断COPD者,按未来急性加重风险分为低危和高危队列,评估未接受指南推荐药物的比例及相关因素。结果显示低危组约54%、高危组约88%接受了充分推荐药物;COPD病程长、合并症多、痴呆及医生年龄较高与未获推荐药物相关,而哮喘共诊、呼吸科医生诊治及接受肺功能检查者更可能获药。
要点
- 低危组约54%、高危组约88%的COPD患者接受了充分的指南推荐药物。
- COPD病程长、合并症多、痴呆及医生年龄较高与未获推荐药物相关。
- 哮喘共诊、呼吸科医生诊治及接受肺功能检查者更可能获得推荐药物。
核心结论
- COPD人群中推荐药物似乎使用不足,多种患者和医生因素与未获推荐药物相关。
研究设计与样本
- 在加拿大安大略省开展的人群队列研究,该省为≥65岁人群提供全民医疗保险和药物覆盖。
- 利用健康行政数据识别2018年≥66岁医生诊断COPD者,并分为未来COPD急性加重低危和高危队列。
- 采用广义估计方程建模分析患者和医生因素与未获推荐药物的关联。
主要发现
- 低危组约54%、高危组约88%的COPD患者接受了充分的推荐药物。
- COPD病程较长、合并症较高、痴呆及医生年龄较高在两个队列中均与未获推荐药物相关。
- 合并哮喘诊断、接受呼吸科医生诊治及接受肺功能检查者更可能获得推荐药物。
临床怎么用
- 对COPD病程长、合并症多、痴呆及由高龄医生管理的患者,应关注推荐药物的处方情况。
- 鼓励呼吸科医生参与诊治和肺功能检查,可能有助于提高推荐药物的接受率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COPD medications reduce exacerbations and improve quality of life. Despite this, some individuals do not receive medications recommended by practice guidelines. RESEARCH QUESTION: How common is nonreceipt of recommended medications among people with COPD, and what factors are associated with nonreceipt? STUDY DESIGN AND METHODS: This population cohort study was conducted in Ontario, Canada, a province with universal health care insurance and medication coverage for those aged ≥ 65 years. Health administrative data were used to identify people aged ≥ 66 years with physician-diagnosed COPD as of 2018 and group them into cohorts of lower or higher risk for future COPD exacerbations. Proportions of patients in each group who did not receive medications recommended by COPD guidelines were determined. Generalized estimating equation modeling was used to determine associations between patient and physician factors and nonreceipt of recommended medications. RESULTS: About 54% and 88% of people with COPD received sufficient recommended medications in the low and high risk of exacerbation groups, respectively. Longer duration of COPD, higher comorbidity, dementia, and older physician age were associated with nonreceipt of recommended medications in both groups. People who had a co-diagnosis of asthma, who received care by a pulmonologist and who received spirometry were more likely to receive recommended medication. INTERPRETATION: COPD medications seem underused by the COPD population, and various factors are associated with suboptimal receipt. Targeting these factors would help improve the care and health of people with COPD.
引用
- Gershon AS, Pequeno P, Alberga Machado A, et al. Factors Associated With Nonreceipt of Recommended COPD Medications: A Population Study. Chest. 2021. PMID: 34144022. doi:10.1016/j.chest.2021.05.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。